Drug intelligence / Profile preview

Ionolyte

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ionolyte is a sterile, isotonic intravenous infusion solution containing sodium chloride, sodium acetate trihydrate, potassium chloride, and magnesium chloride hexahydrate. It is used as a source of water and electrolytes for patients requiring fluid replacement or correction of electrolyte and acid-base imbalances, particularly mild metabolic acidosis. The composition of Ionolyte closely matches plasma electrolyte concentrations to help restore or maintain normal osmotic conditions in both extracellular and intracellular compartments. Acetate in the solution is metabolized to bicarbonate in hepatic and extrahepatic tissues, providing a mild alkalizing effect suitable for patients with a tendency toward acidosis. The pharmacological effects are those of its components—sodium (important for neurotransmission and cardiac electrophysiology), potassium (essential for nerve conduction, muscle contraction, acid-base regulation), magnesium (involved in numerous enzymatic reactions), acetate (bicarbonate precursor), and chloride[1][2][4][6]. Developed by Fresenius Kabi, Ionolyte is primarily indicated for use as an IV fluid replacement therapy in cases such as dehydration or metabolic acidosis.

Brand names
Ionolyte
Other names
Ionolyte Balanced Isotonic CrystalloidMultiple Electrolytes and Sodium AcetateMultiple Electrolytes and Sodium Acetate Injectionmagnesium chloride + potassium chloride + sodium acetate + sodium chloridesodium chloride + sodium acetate + potassium chloride + magnesium chloride
02

Targets

ClC (CLC chloride channel family)Kir (Inward-rectifier potassium channels)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on Ionolyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ionolyte.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call